A modified form of zinc from wheat bran, when given to mice with colon inflammation, leads to higher levels of two specific bile acids in the gut, suggesting a change in how bile acids are processed.

We analyzed the available evidence and found that a modified form of zinc from wheat bran, called enzymatically hydrolyzed wheat bran-derived zinc phytate, is associated with higher levels of chenodeoxycholic acid and lithocholic acid in mice with colitis [1]. This suggests that this zinc compound may influence how bile acids are processed in the gut during colon inflammation, though we cannot say how or why this happens based on the data we’ve reviewed. The evidence we’ve reviewed includes eight supporting assertions and no refuting ones, meaning all current observations point toward this change in bile acid levels. However, we do not know if this effect occurs in humans, or whether it’s directly caused by the zinc compound or linked to other changes in the gut environment. Bile acids like chenodeoxycholic and lithocholic acid are naturally produced by the liver and modified by gut bacteria — their increase could reflect shifts in bacterial activity, gut lining function, or bile flow, but none of these mechanisms were explained in the evidence we examined. We also note that all findings come from mouse studies with colitis, so we cannot assume the same response would happen in healthy animals or people. The studies did not measure long-term effects, safety, or whether these bile acid changes improve or worsen inflammation. What we’ve found so far is limited to one type of zinc supplement in one specific condition — mice with colon inflammation. More research would be needed to understand if this effect is consistent, meaningful, or relevant beyond this setting. If you’re considering this supplement, keep in mind that mouse results don’t always translate to humans, and the impact of these bile acid changes on gut health remains unclear.